Duality Advisers, LP Bluebird Bio, Inc. Transaction History

Duality Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$4.07 - $10.6 $253,740 - $660,846	-62,344 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$8.96 - $16.31 $90,227 - $164,241	10,070 Added 19.26%	62,344 $623,000
Q3 2021 Nov 08, 2021	SELL	$11.24 - $21.0 $474,923 - $887,313	-42,253 Reduced 44.7%	52,274 $999,000
Q2 2021 Aug 09, 2021	BUY	$18.04 - $22.09 $613,143 - $750,794	33,988 Added 56.14%	94,527 $3.02 Million
Q1 2021 May 13, 2021	SELL	$16.59 - $33.89 $570,745 - $1.17 Million	-34,403 Reduced 36.24%	60,539 $1.83 Million
Q4 2020 Feb 09, 2021	BUY	$27.5 - $37.92 $1.04 Million - $1.44 Million	37,932 Added 66.54%	94,942 $4.11 Million
Q3 2020 Nov 12, 2020	BUY	$34.44 - $43.75 $1.96 Million - $2.49 Million	57,010 New	57,010 $3.08 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.